Minerva Neurosciences Inc. buy geldnutzer
Start price
20.02.21
/
50%
€2.92
Target price
2022-02-20
€3.30
Performance (%)
-22.60%
Price
09.04.21
€2.23
This prediction is currently active. The prediction for Minerva Neurosciences Inc. disappoints with a performance of -22.60%. This prediction currently runs until 2022-02-20. The prediction end date can be changed by geldnutzer at any time. geldnutzer has 50% into this prediction
According to geldnutzer what are the pros and cons of Minerva Neurosciences Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Good rating
Standard Investments for future growth
Future proof or reliable business model
Cons
Very low/no dividend yield expected
negative Cash Flow expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bad culture
Little innovation
Growths slower than the competition
high free float
Below average Management
Few uniques
Dependend from some customers or products
Sustainability is little important
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
Comments by geldnutzer for this prediction
In the thread Minerva Neurosciences Inc. diskutieren
Stopped prediction by geldnutzer for Minerva Neurosciences Inc.
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€2.08
€1.80
40.38%
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
